Telesis Bio, Inc.
TBIO
$0.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.03% | -29.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.03% | -29.19% | |||
| Cost of Revenue | -76.29% | 117.10% | |||
| Gross Profit | 226.28% | -172.18% | |||
| SG&A Expenses | -44.77% | 10.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -44.19% | 20.52% | |||
| Operating Income | 50.89% | -34.49% | |||
| Income Before Tax | 46.53% | -46.18% | |||
| Income Tax Expenses | 0.00% | -50.00% | |||
| Earnings from Continuing Operations | 46.53% | -46.16% | |||
| Earnings from Discontinued Operations | 55.08% | -40.85% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 47.22% | -45.71% | |||
| EBIT | 50.89% | -34.49% | |||
| EBITDA | 53.44% | -40.29% | |||
| EPS Basic | 46.26% | -38.04% | |||
| Normalized Basic EPS | 50.40% | -31.25% | |||
| EPS Diluted | 46.26% | -38.04% | |||
| Normalized Diluted EPS | 50.40% | -31.25% | |||
| Average Basic Shares Outstanding | 2.46% | 3.54% | |||
| Average Diluted Shares Outstanding | 2.46% | 3.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
